Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
130-nm albumin-bound paclitaxel
×
Clear all
Filters
3
NCT05017012
2026-01-08
MK-3475A-C18
Merck Sharp & Dohme LLC
Phase 1
Active not recruiting
72 enrolled
NCT02622074
2020-09-10
KEYNOTE 173
Merck Sharp & Dohme LLC
Phase 1
Completed
60 enrolled
26 charts